Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 274M | 393M | 432M | 388M |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 12M | 10M | 12M | 11M |
Other operating expenses | 14M | 13M | 14M | 14M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 248M | 370M | 406M | 363M |
Tax provision | 7M | 13M | 12M | 41M |
Net income | 241M | 357M | 394M | 322M |
Basic EPS | 0.4 | 0.6 | 0.6 | 0.5 |
Diluted EPS | 0.4 | 0.6 | 0.6 | 0.5 |
Basic average shares | 676M | 655M | 635M | 616M |
Diluted average shares | 676M | 655M | 635M | 616M |
EBITDA | — | — | — | — |
Net income from continuing op. | 241M | 357M | 394M | 322M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |